Dr. Emily Keung, MD

• Surgical Oncology

• Critical Care Surgery

• General Surgery

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Harvard Medical School

  Medical School, 2008

• Evaluation of Plasma Interleukin-6 in Melanoma Patients as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker, 2021-12-21

• Disseminated Coccidioidomycosis Following COVID-19 Mimicking Metastatic Thoracic Relapse of Well-Differentiated Liposarcoma: A Case Report, 2021-09-13

• The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care, 2020-11-02

• The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors, 2020-07-30

• Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma, 2022-11-10

• Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists, 2020-10-06

• Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma, 2020-10-20

• Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma, 2022-10-17

• Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020 Cancer Prevalence in Patients With Neurofibromatosis Type 1 vs General Population, 2021-03-18

• Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression, 2017-04-25

• Defining the Incidence and Clinical Significance of Lymph Node Metastasis in Soft Tissue Sarcoma, 2017-11-27

• Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma, 2018-09-24

• Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma, 2022-09-24

• Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma, 2023-03-09

• Neoadjuvant relatlimab and nivolumab in resectable melanoma, 2022-10-26

• Dual Roles of RNF2 in Melanoma Progression, 2015-10-08

• The immune landscape of undifferentiated pleomorphic sarcoma, 2022-10-12

• Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab, 2020-01-03

• The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition, 2023-09-20

• Accurate and Reproducible Diagnosis of Canine Soft Tissue Sarcoma Using Mass Spectrometry: A Step in the Right Direction, 2018-11-12

• Targeting the Molecular and Immunologic Features of Leiomyosarcoma, 2023-03-31

• The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center, 2018-05-03

• Nodal recurrence is a primary driver of early relapse for patients with sentinel lymph node positive melanoma in the modern therapeutic era, 2021-04-15

• B cells and tertiary lymphoid structures promote immunotherapy response, 2020-01-15

• The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum, 2019-06-17

• Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy, 2022-06-15